Several other research firms have also weighed in on UDG. Numis Securities lowered shares of Udg Healthcare to a reduce rating and set a GBX 765 ($10.57) price objective for the company. in a research report on Thursday, November 9th. N+1 Singer raised their price objective on shares of Udg Healthcare from GBX 770 ($10.64) to GBX 841 ($11.62) and gave the company a hold rating in a research report on Wednesday, November 1st. Liberum Capital restated a hold rating and set a GBX 884 ($12.21) price objective on shares of Udg Healthcare in a research report on Wednesday, November 15th. Jefferies Group reduced their price objective on shares of Udg Healthcare from GBX 855 ($11.81) to GBX 800 ($11.05) and set a hold rating for the company in a research report on Monday, December 4th. Finally, Stifel Nicolaus reiterated a hold rating and issued a GBX 815 ($11.26) target price on shares of Udg Healthcare in a report on Thursday, November 30th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. The company currently has an average rating of Hold and an average target price of GBX 832.63 ($11.50).
Udg Healthcare (LON:UDG) opened at GBX 842 ($11.63) on Friday. Udg Healthcare has a 12-month low of GBX 663 ($9.16) and a 12-month high of GBX 963 ($13.30). The firm has a market cap of $2,090.00 and a PE ratio of 4,009.52.
Udg Healthcare Company Profile
UDG Healthcare PLC, formerly United Drug PLC, provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 24 countries and delivering services in over 50 countries. The Company operates across three divisions: Ashfield, which provides commercialization services for the pharmaceutical and healthcare industry and operates across two areas of activity: advisory & communications services and commercial & clinical services and provides healthcare communications, patient support, audit, advisory, medical information and event management services; Sharp, which provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries and operates facilities in the United States and Europe; and Aquilant, which provides outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.